Hifibio inc
WebFounded Date 2013. Founders Jeff He, Liang Schweizer, Robert Nicol. Operating Status Active. Last Funding Type Series D. Also Known As HiFiBiO Therapeutics. Legal Name … WebFind company research, competitor information, contact details & financial data for Hifibio Inc of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.
Hifibio inc
Did you know?
WebHiFiBiO Inc - Company Profile and News - Bloomberg Markets Bloomberg Terminal Demo Request Bloomberg Connecting decision makers to a dynamic network of information, … Web1HiFiBiO Inc., 700 Main Street, Cambridge, MA 02139, USA. Electronic address: [email protected]. 2HiFiBiO Inc., 700 Main Street, Cambridge, MA 02139, USA. PMID: 28941377 DOI: 10.1016/j.drudis.2024.09.003 Abstract Open innovation has become the main trend in pharmaceutical research.
Web22 de mar. de 2024 · AbCellera's full-stack, AI-powered drug discovery platform integrates modern technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. Web14 de jun. de 2024 · HiFiBiO Therapeutics will use the proceeds from the financing to advance two lead antibody oncology assets into Phase I clinical trials - HFB200301, a …
Web高诚生物（HiFiBiO Therapeutics）是一家深耕免疫调节机理并以单细胞技术见长的临床阶段跨国生物制药公司。 目前，公司已实现全球化布局，在美国波士顿剑桥、法国巴黎、中国杭州萧山、上海张江及香港均设有现代化实验室。 公司核心技术为拥有自主知识产权的世界领先的微流控单细胞筛选/分析CelliGO™平台。 通过将专有的单细胞谱分析技术与先进的 … WebFred Dom is a Co-founder of HiFiBiO Inc. and he now serves as the HiFiBiO Therapeutics Chief Financial Officer and Director of French Operations. Mr. Dom is a serial entrepreneur with expertise in private capital investment and operations. Previously, he was CEO of FlexGen (Leiden, the Netherlands) where he spearheaded a commercialization ...
Web17 Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France. [email protected]. 18 HiFiBiO Therapeutics SAS, Paris, France. [email protected]. 19 HiFiBiO Therapeutics Inc., Cambridge, MA, USA. [email protected]. 20 1CellBiO Inc., Watertown, MA, USA. c.brenan@1cell …
Web17 de jun. de 2024 · HiFiBiO to Receive $25 Million Upfront, and Up to a Total of $1.1B in Additional Milestone Payments Across All Three Programs, Plus Royalties; SAN … bitesize compound and complex sentencesWebHFB301001 is a novel human IgG1 agonist antibody that binds to a unique epitope on OX40 allowing for agonistic activity without competing with the endogenous OX40 ligand, inducing minimal OX40 downregulation upon co-stimulation of T cells. Also, HFB301001 can both enhance effector T cells and deplete regulatory T cells. dash ortho scoreWeb6 de jan. de 2024 · HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200603. HFB200603 is a novel anti-BTLA Antibody for the treatment of DIS® … HiFiBiO Therapeutics is an emerging multinational company mobilizing the … HiFiBiO Therapeutics, a multinational clinical-stage biotherapeutics company, … Our unique Drug Intelligence Science (DIS®) approach combines a cutting … For additional information, please email us at: [email protected]. Find us … HiFiBiO Therapeutics Announces Clinical Trial Supply Agreement to Evaluate … bitesize compound interestWeb20 de dez. de 2024 · HiFiBiO Therapeutics is transforming the field of immunotherapy by combining proprietary single-cell profiling technologies with advanced data intelligence and deep knowledge of immune system biology. This approach enables the development of novel antibody therapies that are paired with biomarkers to predict patient response. dash orthoscoresWebHiFiBiO Therapeutics 1 year 10 months Vice President, Global Head of Translational Medicine Apr 2024 - Present1 year 1 month Cambridge, Massachusetts, United States Vice President, Head of... dash or underscoreWebHIFIBIO INC. address:237 Putnam Ave, Cambridge, MA 02139-3807 Telephone:(410) 227-6728 Xi Chenis an attornery registered with New York State, Unified Court System, Office of Court Administration. The admitted year is 2008. The status is Currently registered. Search Attorney Overview das horn wikipediaWeb10 de nov. de 2024 · Director, Global Head of Protein Science at HiFiBiO Therapeutics . Qian Zhang is the Senior Director, Global Head of Lead Evaluation and Protein Science at HiFiBiO Therapeutics. He is a biochemist by training with 10 years of industry experience and expertise in structural biology, analytical chemistry and antibody engineering. dash orthopedic scores